LENSAR, Inc. (LNSR) vs Sensus Healthcare, Inc. (SRTS)
- LENSAR, Inc. LNSR 5.40 −1.82%
- Sensus Healthcare, Inc. SRTS 2.88 −1.37%
LENSAR, Inc. and Sensus Healthcare, Inc. are both Medical Devices companies. LENSAR, Inc. is the larger, with a market value of $67.6M against $48.1M — 1.4× the size. Sensus Healthcare, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 3.9×. LENSAR, Inc. grew revenue faster over the last twelve months: 3.26% against −53.4%. LENSAR, Inc. has the higher net margin (57.6% vs −88.5%) and the lower return on invested capital (−379.0% vs −38.2%). Across the 17 metrics below, LENSAR, Inc. leads on 12 and Sensus Healthcare, Inc. on 5.
Valuation
Profitability
| Metric | LNSR | SRTS | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | 36.39% | 57.76% |
| Operating margin | (13.48%) | (75.72%) | (15.07%) |
| Net margin | 57.57% | (88.45%) | (14.45%) |
| Free cash flow margin | (12.29%) | (39.82%) | (3.88%) |
| Return on equity | (851.75%) | (34.83%) | (10.35%) |
| Return on assets | 49.58% | (30.94%) | (17.26%) |
| Return on invested capital | (379.01%) | (38.22%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack